PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.51%
Revenue growth above 1.5x 3391.T's 2.34%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-2.33%
Negative gross profit growth while 3391.T is at 1.41%. Joel Greenblatt would examine cost competitiveness or demand decline.
-4.92%
Negative EBIT growth while 3391.T is at 0.72%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.57%
Negative operating income growth while 3391.T is at 4.70%. Joel Greenblatt would press for urgent turnaround measures.
-5.25%
Negative net income growth while 3391.T stands at 5.34%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.25%
Negative EPS growth while 3391.T is at 5.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.25%
Negative diluted EPS growth while 3391.T is at 5.29%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3391.T is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.20%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.89%
10Y revenue/share CAGR under 50% of 3391.T's 42.34%. Michael Burry would suspect a lasting competitive disadvantage.
2.89%
5Y revenue/share CAGR under 50% of 3391.T's 42.34%. Michael Burry would suspect a significant competitive gap or product weakness.
-21.33%
Negative 3Y CAGR while 3391.T stands at 20.71%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 3391.T is negative. John Neff would see a structural advantage in sustained cash generation.
100.00%
Positive OCF/share growth while 3391.T is negative. John Neff might see a comparative advantage in operational cash viability.
100.00%
Positive 3Y OCF/share CAGR while 3391.T is negative. John Neff might see a big short-term edge in operational efficiency.
79.77%
Net income/share CAGR at 50-75% of 3391.T's 137.91%. Martin Whitman might question if the firm’s product or cost base lags behind.
79.77%
5Y net income/share CAGR at 50-75% of 3391.T's 137.91%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-8.48%
Negative 3Y CAGR while 3391.T is 58.35%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
37.97%
10Y equity/share CAGR at 50-75% of 3391.T's 68.29%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
37.97%
5Y equity/share CAGR at 50-75% of 3391.T's 68.29%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
-7.15%
Negative 3Y equity/share growth while 3391.T is at 43.07%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.88%
Firm’s AR is declining while 3391.T shows 29.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.67%
Inventory shrinking or stable vs. 3391.T's 22.09%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.78%
Asset growth well under 50% of 3391.T's 22.43%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.84%
50-75% of 3391.T's 5.55%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-13.52%
We’re deleveraging while 3391.T stands at 830.42%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.33%
We cut SG&A while 3391.T invests at 0.55%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.